Head-to-head dispatch
Eden vs Next Vial
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
High-disclosure compounded program — the clearest verification signals in the ranking, at a premium price.
Marked down on: Premium pricing relative to peers
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Desk Score
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.
Marked down on: Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
Eden takes this head-to-head with the higher Desk Score, 85/100 (B) against 62/100 (C) for Next Vial. Next Vial still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Eden
85/100
B
Next Vial
62/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Eden | Next Vial |
|---|---|---|
| Semaglutide | $239/mo | $250/mo (compounded) |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | 49 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who weight clinical transparency and oversight over finding the cheapest rate. | People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. |
| Desk Score | 85/100B | 62/100C |
The verdict
Desk pick — EdenEden takes this head-to-head with the higher Desk Score, 85/100 (B) against 62/100 (C) for Next Vial. Next Vial still holds its ground where its strengths line up with yours.
Choose Eden if…
People who weight clinical transparency and oversight over finding the cheapest rate.
$239/mo sema · $349/mo tirz · All 50 states
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Choose Next Vial if…
People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
$250/mo (compounded) sema · Not disclosed tirz · 49 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Eden · Next Vial.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Eden vs CoreAge Rx
- Next Vial vs Vaylen
- Eden vs Strut Health
- Next Vial vs Ondra Health
- Eden vs Invigor Medical
- Next Vial vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.